“(a) The Company received orders for the sale of pharmaceutical products through introductions made by Mr Yaroslav Farber. In return for the orders and introductions, the Company agreed to pay a commission to Mr Farber that Mr Farber instructed the Company to pay to LCI. (b) Accordingly all payments made to LCI were in consideration of the placing of orders for the resale of pharmaceutical products and were made in the ordinary and proper course of the Company’s business.”
“was opened on the instruction of Mr Farber to receive commission payments due from the Company to him. The monies held in this Credit Suisse account were held for the benefit of Mr Farber and [Mr Mitchell] only made payments out of this account on the instruction of [Mr Silverman] who in turn was acting on the instruction of Mr Farber.”
“In respect of LCI, further information may be available from Mr Jaroslav Farber. I understood that LCI was owned and run by more than one partner, but the sole individual I knew of was Mr Farber. I do not know of Mr Farber’s current whereabouts although I believe he last contacted my father in early July 2006. The only address I have for him is 8 Mukhina, Yalta, Crimea, Ukraine 33403. I do not know the names or contact details of any other individual who may be or have been involved in LCI.”
“All of these shares are held on behalf of Deerfield Services Limited (“Deerfield”), a company I understand to be under the control of Mr Jaroslav Farber. Therefore, whilst they are held in my name, and those of my co-Defendants, I do not regard them as assets belonging to me or my co-Defendants.”
“Properties developed by MPUK are purchased by MPUK with funds belonging to Deerfield. They are held in MPUK’s name on behalf of Deerfield, but the beneficial interest in each property is Deerfield’s. Profits generated by these developments are shared between Deerfield and MPUK. The Defendants’ interests in MPUK are therefore confined in practice to a profit share.”
“10.1.1 I am able to comment in general but not specific terms. Mr Farber represented a number of officials from the Ukrainian Ministry of Health (though I do not know what arrangements were in place between Mr Farber and his associates). Orders for pharmaceuticals were received by the Company via Mr Farber and he was in return paid commissions by the Company through LCI. This amounted to an informal profit sharing arrangement between the Company and LCI. 10.1.2 I had worked with Mr Farber and his associates since the mid 1990s. Later they began to trade in pharmaceuticals. I believe that commissions were initially paid to Mr Farber personally but that as the level of trade increased he decided to establish a company, I believe LCI, to receive payments due to him. 10.1.3 I have no memory of this but I believe that all transactions between LCI and the Company would have been recorded in the Company’s records and in its accounts but I have unable been to verify this as, even if I was well enough to consider them, I do not have access to the Company’s records. 10.1.4 LCI introduced pharmaceutical orders to the Company, and the Company in turn place orders with GlaxoSmithKline Export Limited (“GSK”) or its predecessors. 10.1.5 The Company agreed to pay GSK for the pharmaceuticals ordered according to a payment schedule which was agreed between the parties. The Company would then receive payments for the goods supplied from its customers and commission payments due were made to LCI. 10.2 I am unable to comment on the transfers from the Company to LCI or any payments by LCI as I have no memory of them. I believe the payments made are likely to have been commission payments for business LCI introduced to the Company referred to above. I cannot say what any of the payments by LCI were for as I have no memory of the transferees or why the transfers were made, and I am unable to provide any information as to the current value, nature and location of the funds transferred. 10.3 I have never had any legal or beneficial interest in LCI, and have never exercised direct or indirect control over LCI. 11.1 In respect of LCI, further information may be available from Mr Jaroslav Farber. Whilst I understood that LCI was owned and run by more than one person, the only individual that I knew of was Mr Farber. The only address I have for him is 8 Mukhina, Yalta, Crimea, Ukraine 33403.”
“As to the contact details I have provided for Mr Farber, the information at paragraph 11.1 of my first affidavit is the only information I am able to provide. I have complied with my obligation to provide information to the best of my ability. Whilst I have met Mr Farber, business communications were made solely between Mr Farber and the Second Defendant. The Claimant’s solicitors state that the address I have provided “does not appear to exist” but they do not say what leads them to this conclusion. It was my understanding that the address is that of the Institute of Child Healthcare in Yalta, and that Mr Farber had offices in this complex.”
“a mechanism for providing commission payments to Mr Farber and his associates. I do not know why this additional step (in addition to the use of LCI) was put in place. I have been unable to explain why the account was set up, because I do not have that information. I believe that the Second Defendant would be able to provide an explanation, if he was well enough to do so.”
“Throughout my involvement with the Claimant, I acted on the Second Defendant’s instructions. I did not question those instructions or seek further information from him. With hindsight, I now accept that this may have been naïve. However, I have no reason to believe that the Second Defendant acted improperly.”
“I believed that the£300,000 transferred to Fidecs was a sum payable to Deerfield under the profit sharing arrangement between MPUK and Deerfield. I accept that this was an irrational conclusion for me to have drawn in view of the timing of the transfer and the elaborate nature of the series of transfers of which it formed part. With hindsight I now accept that those transfers amounted to an attempt to put assets beyond the reach of the Claimant. I did not believe that I had any beneficial interest in the£300,000 ,”
“8.1 At paragraph 10.5.12 of my first affidavit and paragraph 15 of my second affidavit, I stated that I did not know why the payments from Lake Charles Inc (“LCI”) to Fidecs Management Limited (“Fidecs”) listed at Annex B to the Particulars of Claim were made, and that I had no knowledge of the entity to which they were made (i.e. the entities on whose behalf Fidecs held the sums transferred). Those statements are false: as I explain below, I did have some knowledge as to why payments were being made to Fidecs, and of what sort of entity Fidecs was. I admit that I did not give proper consideration to these payments and therefore failed to disclose information that I should have provided in my earlier affidavits. I regret that failure and sincerely apologise to the court for it. 8.2 I accept that I myself notified Fidecs that it would be receiving some of the Annex B payments (and other payments) and that I gave instructions as to what Fidecs should do with the monies received. Prior to receiving the documents exhibited at pages 10-56 of AM1, I did not connect the “Annex B” payments made from LCI to Fidecs to the payments in respect of which I gave instructions to Fidecs. Given the large sums of money involved, I accept that I should have done so. I should also have remembered, and stated, that the payments in respect of which I gave instructions to Fidecs related to investments by the Second Defendant’s Ukrainian partners on specific property developments. I should have stated that I knew that Fidecs operated accounts on behalf of those partners in the names of Deerfield and Heaton Moor. 8.3 Even if I had been unable to recall which transaction a specific payment related to, I should have been able to obtain further information in respect of those transactions from third parties (most obviously the conveyancing solicitors, Edward Oliver, from whom I and my co-defendants have now requested copies of all documentation held by them: pages 12-15 of MDAM5). 8.4 However, I maintain that whenever I gave instructions to Fidecs I was simply relaying the Second Defendant’s instructions to me. I have not yet been able to ascertain what became of the monies transferred by Fidecs on those instructions but I will make every effort to do so and to facilitate enquiries by my solicitors and the Claimant’s solicitors in this regard.”
“I think it right to ask, using the words of Ackner L.J. in the Banque de Paris case, at p. 23, "Is there a fair or reasonable probability of the defendants having a real or bona fide defence?" The test posed by Lloyd L.J. in the StandardChartered Bank case, Court of Appeal (Civil Division), Transcript No. 699 of 1990 "Is what the defendant says credible?," amounts to much the same thing as I see it. If it is not credible, then there is no fair or reasonable probability of the defendant having a defence.”
“It is of course trite law that Order 14 proceedings are not decided by weighing the two affidavits. It is also trite that the mere assertion in an affidavit of a given situation which is to be the basis of a defence does not, ipso facto, provide leave to defend; the court must look at the whole situation and ask itself whether the defendant has satisfied the court that there is a fair or reasonable probability of the defendants having a real or bona fide defence.”
“57. I do not underestimate the importance of a finding adverse to the integrity to one of the parties. In itself, the risk of such a finding may provide a compelling reason for allowing a case to proceed to full oral hearing, notwithstanding the apparent strength of the claim on paper, and the confident expectation, based on the papers, that the defendant lacks any real prospect of success. Experience teaches us that on occasion apparently overwhelming cases of fraud and dishonesty somehow inexplicably disintegrate. In short, oral testimony may show that some such cases are only tissue paper strong. As Lord Steyn observed in Medcalf v Weatherill [2003]1 AC120 at paragraph 42, when considering wasted costs orders: "The law reports are replete with cases which were thought to be hopeless before investigation but were decided the other way after the Court had allowed the matter to be tried". And that is why I commented in Esprit Telecoms UK Ltd and others -v- Fashion Gossip Ltd , unreported,27 July 2000 that I was "troubled about entering summary judgment in a case in which the success of the claimant's case involves, as this one does, establishing allegations of dishonesty and fraud, which are strongly denied, and which cannot be conclusively proved by, for example, a conviction before a criminal court." 58. This collective judicial experience does not always, or inevitably, provide a compelling reason for allowing the case to proceed to trial, nor for that matter require the judge considering the application to reject the conclusion that there is no real prospect of a successful defence of the claim if he is satisfied that there is none. That is not what the Rules provide, and if that had been intended, express provision would have been made. It is however a factor constantly to be borne in mind, if and when, as here, the reason for concluding summary judgment is appropriate is consequent on a disputed finding, adverse to the integrity of the unsuccessful party.”
“To clarify the monies paid to Lake Charles Inc. there has never been any requests by the liquidator for any explanations regarding these. These transactions comprised a number of payments made over a period of time and all related to purchases made in 2001, 2002. These payments reflected the trading and credit terms that UK AID LTD had with both GSK and Lake Charles Inc. and are recorded in the audited accounts. The proof of consideration of goods is undeniable, as all supporting documentation for the company’s sales and purchases, including all dealings with Lake Charles Inc. were presented to the auditors for the preparation of the accounts.”
“8.2.2 It was at all times and remains my understanding and belief that LCI was owned by Mr Yaroslav Farber. I understand from the Second Defendant that Mr Farber represented a number of officials from the Ukrainian Ministry of Health (though I do not know what arrangements were in place between Mr Farber and his associates). Orders for pharmaceuticals were received by the Company via Mr Farber and he was in return paid commissions by the Company through LCI. This amounted to an informal profit sharing arrangement between the Company and LCI. 8.2.3 It was at all times and remains my understanding that the Second Defendant had worked with Mr Farber and his associates since the mid 1990s. I understood that they traded in metals, oil, sugar, wheat, and that in 1997 they began to trade in pharmaceuticals. I believe that commissions were initially paid to Mr Farber personally but that as the level of trade increased he decided to establish LCI to receive payments due to him. 8.2.4 To the best of my recollection, all transactions between LCI and the Company were recorded in the Company’s records and in its accounts but I have unable been to verify this as I do not have access to the Company’s records. 8.2.5 LCI introduced pharmaceutical orders to the Company, and the Company in turn place orders with GlaxoSmithKline Export Limited (“GSK”) or its predecessors. The Company’s point of contact within GSK was Richard Jones. 8.2.6 The Company agreed to pay GSK for the pharmaceuticals ordered according to a payment schedule which was agreed between the parties. The Company would receive payments for the goods supplied from its customers and payments due were made to LCI. 8.2.8 As to the eleven transactions referred to at paragraph 9.2 below, to the best of my knowledge and belief, these were commission payments made in the ordinary course of business between the Company and LCI.”
“I believe that these payments were broken down as follows.£1,549,712 related to purchases paid (please see the invoice no 3005/01 from LCI dated5 March 2002 at page 238 of IJH1). The remaining£3,472,968 constituted commission/profit share payments. The commissions paid equate to under half of UK (Aid)’s turnover. I believe that this was the basis of the informal profit sharing arrangement between the company and LCI, but I was not made aware by the Second Defendant of the details of that arrangement.”
“Commission payments 8. Mr Hastings argues, at paragraphs 7, 8 and 9(a) of his witness statement, that the payments made from UK (Aid) to Lake Charles Inc (“LCI”) cannot have been legitimate commission payments. Arrangements in respect of commission payable by UK (Aid) to LCI were made by the Second Defendant, and I do not therefore have first hand knowledge of them. I understood that the commission payments were made to LCI in return for the introduction of business to UK (Aid) by Mr Farber. 9. With the help of UK (Aid)’s accountants, I have described my understanding of the basis on which the commissions were paid at paragraph 8.2 of my first affidavit and paragraphs 24 to 26 of my second affidavit. Lake Charles Inc 10. At paragraph 9(b) of Mr Hastings’ witness statement he states that I have not explained why it was necessary for LCI to be established in order to receive commission payments. I have provided as much information as I am able to give in relation to LCI at paragraphs 8.2.2 and 8.2.3 of my first affidavit. I understood LCI to be a company controlled and operated by Mr Farber and his associates. I can only speculate as to why UK (Aid)’s Ukrainian partners chose to receive commission payments through a BVI company, but I think it is entirely plausible that they should not wish to receive payments directly. I understood that they were employees of the Ukrainian Ministry of Health and they may have wished to avoid drawing attention to the sums of money they were receiving. I would reject the suggestion that there is anything inherently sinister in this arrangement.”
“It was my genuine understanding that the monies paid to LCI were commission payments for Mr Farber and his associates.”
“I recall that he informed me that Mr Farber wanted payments to be made into a Swiss account because of concerns over the stability of the Russian currency. I cannot provide details of when commission/profit share payments were made as I do not have any records. I am therefore unable to say more as to what became of the$265,000 transferred into this account. The Claimant’s solicitors insist that my disclosure in relation to my Credit Suisse account is “obviously inadequate” but they do not explain why. I have already stated everything that I am able to tell them about this account.”
“Further to our conversation, you should now have received£400,000 for Heaton Moor Ltd to invest in the properties previously discussed. Please now transfer these funds to our solicitor so that he can exchange contracts on Heaton Moor Ltd’s behalf.”
“I have been advised that£150,000 is being transferred to your account, ref Heaton Moor Ltd, for the completion of 5 Blackstock Mews.”
“8.1 At paragraph 10.5.12 of my first affidavit and paragraph 15 of my second affidavit, I stated that I did not know why the payments from Lake Charles Inc (“LCI”) to Fidecs Management Limited (“Fidecs”) listed at Annex B to the Particulars of Claim were made, and that I had no knowledge of the entity to which they were made (i.e. the entities on whose behalf Fidecs held the sums transferred). Those statements are false: as I explain below, I did have some knowledge as to why payments were being made to Fidecs, and of what sort of entity Fidecs was. I admit that I did not give proper consideration to these payments and therefore failed to disclose information that I should have provided in my earlier affidavits. I regret that failure and sincerely apologise to the court for it. 8.2 I accept that I myself notified Fidecs that it would be receiving some of the Annex B payments (and other payments) and that I gave instructions as to what Fidecs should do with the monies received. Prior to receiving the documents exhibited at pages 10-56 of AM1, I did not connect the “Annex B” payments made from LCI to Fidecs to the payments in respect of which I gave instructions to Fidecs. Given the large sums of money involved, I accept that I should have done so. I should also have remembered, and stated, that the payments in respect of which I gave instructions to Fidecs related to investments by the Second Defendant’s Ukrainian partners on specific property developments. I should have stated that I knew that Fidecs operated accounts on behalf of those partners in the names of Deerfield and Heaton Moor. 8.3 Even if I had been unable to recall which transaction a specific payment related to, I should have been able to obtain further information in respect of those transactions from third parties (most obviously the conveyancing solicitors, Edward Oliver, from whom I and my co-defendants have now requested copies of all documentation held by them: pages 12-15 of MDAM5). 8.4 However, I maintain that whenever I gave instructions to Fidecs I was simply relaying the Second Defendant’s instructions to me. I have not yet been able to ascertain what became of the monies transferred by Fidecs on those instructions but I will make every effort to do so and to facilitate enquiries by my solicitors and the Claimant’s solicitors in this regard. 9.1 None of LCI, Heaton Moor, Deerfield or Bawdwin were set up on my instructions. I do not know how these companies were set up and I am not aware of any other BVI companies. I was a signatory in respect of the Bawdwin account but I did not give instructions in respect of the LCI, Heaton Moor and Deerfield accounts. I do not know why BVI companies were used or what became of the profits made from the sale of properties purchased through them. The Second Defendant dealt with the accounting to his Ukrainian partners for profits made on developments. I maintain that it was my genuine understanding that the monies paid to LCI were commission payments for Mr Farber and his associates.”
“We take note of your comments that under no circumstances would UK-AID’s books and records ever be passed on to GSK, unless they obtained a court order for some reason. In any event this would be irrelevant as we confirmed yesterday, the books and records were placed in storage in a garage adjacent to our office. Whilst I was on holiday, workmen cleared furniture and rubbish from this garage and removed a number of boxes, some of which contained the records. However you do have full audited accounts and other relevant financial information supplied by M.P. Saunders & Co.”
“We have supplied confirmation to the liquidators regarding the books and records as stated in our letter of Oct 22nd 2003. This letter covered the points raised at our meeting with KPMG of Oct 21st 2003. We did not state that the books and records had been destroyed, but rather had been mislaid and we were investigating the matter. Subsequently, as the records were boxed in empty GSK packing boxes, we believe that they were delivered to KPMG with the rest of the similar boxes containing the stock. On receipt, KPMG for reasons of their own immediately transferred all the boxes to GSK, who then destroyed them, without prior, written authorisation. The delivery occurred on Friday October 17th 2003 and our meeting with KPMG was on Tuesday October 21st.At the meeting KPMG confirmed receipt of the delivery, which had been forwarded on to GSK, they confirmed that they had not received the books and because we believed that they had checked everything we could only assume that they had been mislaid, we informed KPMG as such and stated that we would investigate further.”